Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Completes Medical Cannabis Export to Barbados

GlobeNewswire November 26, 2021

MediPharm Labs Expands CBN Portfolio with Two New Products

GlobeNewswire November 23, 2021

MediPharm Reports Third Quarter 2021 Results; Announces New CEO to Start Today

GlobeNewswire November 15, 2021

MediPharm Labs Sets Date to Report Third Quarter 2021 Financial Results

GlobeNewswire November 10, 2021

MediPharm Labs (TSX:LABS) appoints new CEO

Brieanna McCutcheon  October 21, 2021

MediPharm Labs Appoints New Chief Executive Officer

GlobeNewswire October 21, 2021

MediPharm Labs (TSX:LABS) announces cannabis oil delivery to Vayamed

John Ballem  October 19, 2021

MediPharm Labs Completes a New Cannabis Oil Delivery to German Partner Vayamed

GlobeNewswire October 19, 2021

Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent

GlobeNewswire August 31, 2021

MediPharm Labs Australia Receives Government Grant to Assist with International Expansion

GlobeNewswire August 19, 2021

MediPharm Labs (TSX:LABS) receives export authorization from Brazil

Trevor Abes  August 18, 2021

MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil

GlobeNewswire August 18, 2021

MediPharm (TSX:LABS) reports second-quarter 2021 results

Brieanna McCutcheon  August 16, 2021

MediPharm Reports Second Quarter 2021 Results and Advances Pharmaceutical Strategy; Announces new Board Chair

GlobeNewswire August 16, 2021

MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results

GlobeNewswire August 10, 2021

MediPharm Labs (TSX:LABS) receives Canadian GMP license

Trevor Abes  July 14, 2021

MediPharm Labs Achieves Major Pharmaceutical Manufacturing Milestone: Receives Canadian GMP Pharmaceutical Drug Establishment Licence

GlobeNewswire July 14, 2021

MediPharm Labs (TSX:LABS) enters research agreement with McMaster University

Julia Kennedy  June 21, 2021

MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates

GlobeNewswire June 21, 2021

MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Shareholders

GlobeNewswire June 10, 2021